PureShield, Inc. v. Allied BioScience, Inc.

CourtDistrict Court, E.D. Texas
DecidedSeptember 30, 2021
Docket4:20-cv-00734
StatusUnknown

This text of PureShield, Inc. v. Allied BioScience, Inc. (PureShield, Inc. v. Allied BioScience, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
PureShield, Inc. v. Allied BioScience, Inc., (E.D. Tex. 2021).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS SHERMAN DIVISION

PURESHIELD, INC., ET AL. § § v. § CIVIL NO. 4:20-CV-734-SDJ § ALLIED BIOSCIENCE, INC. §

MEMORANDUM OPINION AND ORDER Before the Court is Defendant Allied BioScience, Inc.’s (“ABS”) Rule 12(b)(6) Partial Motion to Dismiss for Failure to State a Claim Upon Which Relief Can Be Granted. (Dkt. #19). The motion seeks dismissal of Plaintiffs PureShield, Inc. and ViaClean Technologies, LLC’s (collectively, “ViaClean”) state-law claim against ABS for tortious interference with a prospective business relationship. ViaClean has responded in opposition, (Dkt. #23), and the Court held a hearing on the motion, (Dkt. #32). Because ViaClean’s allegations fail to meet the plausibility standard of Twombly and Iqbal as to several elements of its tortious-interference claim, ABS’s motion will be GRANTED. I. BACKGROUND ViaClean and ABS are competitors in the antimicrobial products industry. ViaClean’s products, which are registered with the Environmental Protection Agency (“EPA”), are intended to be applied to surfaces to protect against germs for up to ninety days. In 2020, ABS obtained an EPA emergency regulatory exemption to use its antimicrobial product, SURFACEWISE2, without undergoing a full EPA registration process and began marketing the product.1 ViaClean contends that ABS “has been falsely advertising SURFACEWISE2 as the first ever EPA-registered protectant effective against pathogens.” (Dkt. #1 ¶ 35). ViaClean further accuses ABS

of “disparag[ing] its competition—including [ViaClean]—with false statements” by way of ABS’s assertions on its website that “[t]here are no other EPA-registered products that offer lasting sanitization” and that “[c]ompanies claiming their products offer residual control of viruses and coronaviruses are doing so illegally.” (Dkt. #1 ¶¶ 36–37); (Dkt. #1-28 at 4). ViaClean, however, is “fully authorized to sell [its] EPA-registered antimicrobial products.” (Dkt. #1 ¶ 37).

Based on these and related contentions, ViaClean brought this action asserting patent infringement, false advertising, unfair competition, and tortious interference claims against ABS. On the parties’ joint motion, the Court severed and stayed Counts I–X of the Complaint pending resolution of the disputes between ViaClean and non-party Novalent, Ltd. regarding rights in and to the patents asserted in this case. (Dkt. #18). Counts XI–XIII, which include ViaClean’s false advertising, unfair competition, and tortious interference claims, are moving forward.

1 The exemption was scheduled to expire on August 24, 2021, and limited the product for use only on certain surfaces to combat coronavirus at “27 American Airlines aircraft and airport facilities in Texas” and “two Total Orthopedics Sports and Spine facilities in Texas.” (Dkt. #1-23 at 1); (Dkt. #1-24 at 1). However, on July 8, 2021, the EPA “issued a Stop Sale, Use or Removal Order (SSURO) to Allied BioScience for their product SurfaceWise2” and revoked the emergency regulatory exemption after finding that ABS had been “marketing, selling, and distributing SurfaceWise2 in ways that were inconsistent with the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), EPA’s regulations, and the terms and conditions of the emergency exemption authorizations.” (Dkt. #38-1 at 1). As relevant here, Count XII2 of ViaClean’s Complaint asserts that, through ABS’s alleged “false and misleading marketing regarding competing products—such as those offered by [ViaClean],” ABS “has and continues to tortiously interfere with

[ViaClean’s] prospective business relations in violation of Texas’s tortious interference common law.” (Dkt. #1 ¶¶ 191, 193). ViaClean further alleges in Count XI of the Complaint that ABS “openly and explicitly deceives consumers by way of false advertisements in violation of 15 U.S.C. § 1125(a),” Section 43 of the Lanham Act. (Dkt. #1 ¶ 178). ViaClean’s tortious-interference claim turns on the contention that ABS has

and continues to violate Texas law by tortiously interfering with ViaClean’s prospective business relations. Specifically, ViaClean alleges that: (1) ABS’s “false and misleading marketing statements have actually interfered and are likely to continue interfering with [ViaClean’s] prospective business relations in the same market segment”; (2) but for ABS’s false and misleading marketing, “[t]here was a reasonable probability that [ViaClean] would have entered into a business relationship with third parties, including customers or business partners”; (3) “ABS

willfully, intentionally interfered with [ViaClean’s] prospective business relations with customers” through their alleged marketing tactics; and (4) “[a]s a direct and

2 The Complaint identifies ViaClean’s tortious-interference claim as “Count XII,” but this is obviously a typo. Based on the twelve previous counts listed and numbered in the Complaint, the tortious interference claim should have been identified as “Count XIII.” See (Dkt. #1 at 25–56). In this order the Court will reference the cause of action at issue as ViaClean’s claim for tortious interference with prospective business relations or as ViaClean’s tortious-interference claim. proximate result of ABS’s misconduct,” ViaClean has been injured “in the form of actual damages, including lost sales and lost profits.” (Dkt. #1 ¶¶ 192–194). ABS has moved to dismiss ViaClean’s tortious-interference claim under

Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim upon which relief can be granted. ABS contends that ViaClean’s “threadbare allegations fall far short of the pleading requirements for this claim under Texas law” and “are mere recitations of the elements of this cause of action with little to no factual support.” (Dkt. #19 at 1). II. LEGAL STANDARD

Rule 12(b)(6) provides that a pleading may be dismissed for “failure to state a claim upon which relief can be granted.” FED. R. CIV. P. 12(b)(6). For a claimant to “survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). The plausibility standard is met when “the plaintiff pleads factual content that

allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” United States v. Bollinger Shipyards, Inc., 775 F.3d 255, 260 (5th Cir. 2014) (citing Iqbal, 556 U.S. at 678). “Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Iqbal, 556 U.S. at 678. Further, “[t]o raise a right to relief, the complaint must contain either direct allegations or permit properly drawn inferences to support ‘every material point necessary to sustain a recovery’; thus, ‘[d]ismissal is proper if the complaint lacks an allegation regarding a required element necessary to obtain relief.’” Torch Liquidating Tr. v. Stockstill, 561 F.3d 377, 384 (5th Cir. 2009) (quoting Campbell v.

City of San Antonio, 43 F.3d 973, 975 (5th Cir. 1995)). Texas law governs ViaClean’s tortious-interference claim.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Campbell v. City of San Antonio
43 F.3d 973 (Fifth Circuit, 1995)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Marlin v. Robertson
307 S.W.3d 418 (Court of Appeals of Texas, 2009)
Doe v. Boys Clubs of Greater Dallas, Inc.
907 S.W.2d 472 (Texas Supreme Court, 1995)
Wal-Mart Stores, Inc. v. Sturges
52 S.W.3d 711 (Texas Supreme Court, 2001)
Farouk Systems, Inc. v. Costco Wholesale Corp.
700 F. Supp. 2d 780 (S.D. Texas, 2010)
M-I LLC v. Stelly
733 F. Supp. 2d 759 (S.D. Texas, 2010)
United States v. Bollinger Shipyards, Inc.
775 F.3d 255 (Fifth Circuit, 2014)
Delz v. Winfree, Norman & Pearson
16 S.W. 111 (Texas Supreme Court, 1891)
Cooper v. Harvey
108 F. Supp. 3d 463 (N.D. Texas, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
PureShield, Inc. v. Allied BioScience, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/pureshield-inc-v-allied-bioscience-inc-txed-2021.